Cargando…

Commentary on: The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia

Detalles Bibliográficos
Autor principal:	Nasri, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810586/ https://www.ncbi.nlm.nih.gov/pubmed/24174957

Ejemplares similares

The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Allopurinol-induced hypersensitivity syndrome followed by painless thyroiditis in a patient with asymptomatic hyperuricemia
por: Chen, Xiaolin, et al.
Publicado: (2020)

Comment on: Prevention of Renal Damage by Treating Hyperuricemia
por: Nasri, Hamid, et al.
Publicado: (2015)

Hyperuricemia and non-dipping blood pressure
por: Marrone, Oreste, et al.
Publicado: (2013)

Know Your Blood Pressure; the Theme of World Hypertension Day 2014
por: NASRI, Hamid
Publicado: (2014)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

Commentary on: Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?
por: Nasri, Hamid
Publicado: (2013)

Commentary on: Effects of Cinnamon Consumption on Glycemic Status, Lipid Profile and Body Composition in Type 2 Diabetic Patients
por: Nasri, Hamid, et al.
Publicado: (2013)

Hemodialysis in COVID-19 Patients: Yes or No? A Commentary
por: Hosseini, Amin, et al.
Publicado: (2020)

Blood pressure lowering in pregnancy
por: Sobieraj, Piotr
Publicado: (2021)

Clinical Potential of Allopurinol in the Treatment of Bipolar Disorder
por: Bishnoi, Ram J.
Publicado: (2014)

Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients
por: Nasri, Hamid
Publicado: (2014)

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
por: Kim, Sollip, et al.
Publicado: (2017)

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study
por: Alghamdi, Youssef Saeed, et al.
Publicado: (2020)

Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2022)

Synergistic Impacts of Alpinia oxyphylla Seed Extract and Allopurinol against Experimental Hyperuricemia
por: Sung, Yoon-Young, et al.
Publicado: (2022)

Febuxostat versus allopurinol for patients with gout: is it time to overcome concerns regarding cardiovascular safety?
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2021)

Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study
por: Sugano, Naoki, et al.
Publicado: (2019)

Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia
por: Liao, Zhimin, et al.
Publicado: (2022)

Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients
por: Rohn, Benjamin, et al.
Publicado: (2020)

Allopurinol increased the risk of COVID-19 hospitalization mediated by E-Selectin downregulation
por: Zhang, Kai, et al.
Publicado: (2023)

Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients
por: Li, Yanchun, et al.
Publicado: (2019)

Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial
por: Suzuki, Satoshi, et al.
Publicado: (2021)

Switching from allopurinol to febuxostat: efficacy and tolerability in hemodialysis patients
por: Mitsuboshi, Satoru, et al.
Publicado: (2015)

Significance of hyperuricemia in immunoglobulin A nephropathy
por: Nasri, Hamid, et al.
Publicado: (2013)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
por: Deng, Jian‐Hao, et al.
Publicado: (2022)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

Acidosis with hyperuricemia and renal tubular damage in viral gastroenteritis
por: Morita, Taku, et al.
Publicado: (2011)

Comment on: The effects of green tea consumption on metabolic and anthropometric indices in patients with type 2 diabetes
por: Nasri, Hamid, et al.
Publicado: (2014)

Commentary on “Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms”
por: Birder, Lori
Publicado: (2020)

Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats
por: Nasri, Hamid
Publicado: (2013)

The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study
por: Nematbakhsh, Mehdi, et al.
Publicado: (2013)

Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
por: Huang, Jin-Xian, et al.
Publicado: (2023)

Viruses may trigger allopurinol hypersensitivity syndrome
por: Koike, Masami, et al.
Publicado: (2008)

Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
por: Nasri, Hamid
Publicado: (2014)

Blood Pressure Lowering Decreases Intracerebral Hemorrhage Volume and Improves Behavioral Outcomes in Experimental Animals
por: Bohmann, Ferdinand O., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l2nkd9tp0js8kfb94ovillf61n